Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients

Table 4

Summary of apheresis yields in the different groups of patients.

	CD34+ ×10^6/kg Median (range)	Median days of apheresis/cycle	Median no. of CFU-GM ×10^5/kg*
MM
Poor mobilizers (𝑛=8); Good mobilizers (𝑛=10)	8.38 (2.4–25.1); 10.1 (6.4–12.3)	4 (2–5); 2 (2-3)	5.15 (0.45–9.3); 3.87 (0.0–13.9)^†
Lymphoma
Poor Mobilizers (𝑛=9); Good Mobilizers (𝑛=15)	3.85 (1.17–8.98); 5.56 (2.1–14.7)	3 (1–4); 2 (2–4)	2.01 (0.66–6.53); 2.01 (0.42–10.6)

*These numbers are from day 1 collection.
^†One patient had 0 CFU-GM in one CFU assay.